This seems like an interesting alternative to relying on synthetic grafts ... outcomes with arteriovenous fistula procedures). Higher patency rates and longer duration of dialysis were achieved ...

It also suggests the potential for NVS Therapy to enhance fistula maturation in the clinical setting. BA and KK were employed by company Alucent Biomedical Inc. The funder Alucent Biomedical, Inc. was ...

Failed to fetch dynamically imported module: https://uk.finance.yahoo.com/assets/_app/immutable/nodes/96.Cy8eSqq3.js ...

Merit Medical Systems has received premarket approval from the US Food and Drug Administration (FDA) for its WRAPSODY Cell-Impermeable Endoprosthesis allowing the company to commercially launch ...

Artivion, Inc. E-xpand Stent Graft Balloon Catheter 12 (minimum sheaths) 0.035 Designed to assist in stent graft procedures; compliant balloon; radiopaque markers for exact placement; short inflation ...

Many patients undergoing dialysis rely on a vascular access site created in the arm called an arteriovenous (AV) fistula (surgically joining an artery and vein) or an AV graft (a soft tube placed in ...

In our practice, a commitment to autologous access began even before the publication of the DOQI guidelines. Early in our experience, prosthetic grafts were generally the third line of ...

Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...

and arteriovenous fistula. Renal artery thrombosis is an early (within the first 2 days posttransplantation) technical complication that leads to graft loss and requires allograft nephrectomy.

Are you preparing to begin dialysis? Vascular surgeon Rebecca Marmor from Johns Hopkins Howard County Medical Center reviews general information about creating dialysis access (including information ...